These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 3528863)
1. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Prochownik EV; Kukowska J Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863 [TBL] [Abstract][Full Text] [Related]
2. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861 [TBL] [Abstract][Full Text] [Related]
3. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation. Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709 [TBL] [Abstract][Full Text] [Related]
4. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
10. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation. Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254 [TBL] [Abstract][Full Text] [Related]
11. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109 [TBL] [Abstract][Full Text] [Related]
12. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells. Sasaki H; Watanabe T; Nomura S; Oishi M Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between expression of c-myc and P53 genes and terminal differentiation during induced differentiation in Friend erythroleukemia cells]. Liu HT; Zhang HQ; Xue SB; Du CY; You JS; Song PG; Wang XL; Chen RX Shi Yan Sheng Wu Xue Bao; 1988 Sep; 21(3):311-9. PubMed ID: 3066081 [No Abstract] [Full Text] [Related]
15. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. Kirsch IR; Bertness V; Silver J; Hollis GF J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612 [TBL] [Abstract][Full Text] [Related]
17. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861 [TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system. Tsiftsoglou AS; Wong W Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045 [TBL] [Abstract][Full Text] [Related]
19. [The induction of high-level expression of a novel VL-30 like gene during the chemical-inducing erythroid differentiation of murine erythroleukemia cells (MEL)]. Chen Y; Liu D; Xue S Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):30-3. PubMed ID: 11877048 [TBL] [Abstract][Full Text] [Related]
20. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters. Kohlhuber F; Strobl LJ; Eick D Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]